TY - JOUR
T1 - Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV)
T2 - a randomised controlled trial
AU - CORDIOPREV Investigators
AU - Delgado-Lista, Javier
AU - Alcala-Diaz, Juan F.
AU - Torres-Peña, Jose D.
AU - Quintana-Navarro, Gracia M.
AU - Fuentes, Francisco
AU - Garcia-Rios, Antonio
AU - Ortiz-Morales, Ana M.
AU - Gonzalez-Requero, Ana I.
AU - Perez-Caballero, Ana I.
AU - Yubero-Serrano, Elena M.
AU - Rangel-Zuñiga, Oriol A.
AU - Camargo, Antonio
AU - Rodriguez-Cantalejo, Fernando
AU - Lopez-Segura, Fernando
AU - Badimon, Lina
AU - Ordovas, Jose M.
AU - Perez-Jimenez, Francisco
AU - Perez-Martinez, Pablo
AU - Lopez-Miranda, Jose
AU - Almaden Peña, Yolanda
AU - Aranda, Enrique
AU - Arenas de Larriva, Antonio P.
AU - Badimon, Juan J.
AU - Blanco-Molina, Angeles
AU - Blanco-Rojo, Ruth
AU - Bolivar-Muñoz, Julia
AU - Caballero-Villarraso, Javier
AU - Chica, Javier
AU - Corina, Andreea
AU - Criado-Garcia, Juan
AU - Cruz-Teno, Cristina
AU - Daponte-Codina, Antonio
AU - de Teresa Galvan, Eduardo
AU - Delgado-Casado, Nieves
AU - Estruch, Ramon
AU - Fernandez, Juan M.
AU - Fernandez-Gandara, Carolina
AU - Fuentes-Jimenez, Francisco
AU - Garcia-Carpintero Fernandez-Pacheco, Sonia
AU - Gomez-Delgado, Francisco
AU - Gomez-Garduño, Angela
AU - Gomez-Luna, Purificacion
AU - Gomez-Luna, Maria J.
AU - Gonzalez-Guardia, Lorena
AU - Gonzalez-Requero, Ana I.
AU - Gutierrez-Mariscal, Francisco M.
AU - Haro-Mariscal, Carmen M.
AU - Jimenez-Lucena, Rosa
AU - Jimenez-Morales, Ana I.
AU - Leon-Acuña, Ana
N1 - Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/5/14
Y1 - 2022/5/14
N2 - Background: Mediterranean and low-fat diets are effective in the primary prevention of cardiovascular disease. We did a long-term randomised trial to compare the effects of these two diets in secondary prevention of cardiovascular disease. Methods: The CORDIOPREV study was a single-centre, randomised clinical trial done at the Reina Sofia University Hospital in Córdoba, Spain. Patients with established coronary heart disease (aged 20–75 years) were randomly assigned in a 1:1 ratio by the Andalusian School of Public Health to receive a Mediterranean diet or a low-fat diet intervention, with a follow-up of 7 years. Clinical investigators (physicians, investigators, and clinical endpoint committee members) were masked to treatment assignment; participants were not. A team of dietitians did the dietary interventions. The primary outcome (assessed by intention to treat) was a composite of major cardiovascular events, including myocardial infarction, revascularisation, ischaemic stroke, peripheral artery disease, and cardiovascular death. This study is registered with ClinicalTrials.gov, NCT00924937. Findings: From Oct 1, 2009, to Feb 28, 2012, a total of 1002 patients were enrolled, 500 (49·9%) in the low-fat diet group and 502 (50·1%) in the Mediterranean diet group. The mean age was 59·5 years (SD 8·7) and 827 (82·5%) of 1002 patients were men. The primary endpoint occurred in 198 participants: 87 in the Mediterranean diet group and 111 in the low-fat group (crude rate per 1000 person-years: 28·1 [95% CI 27·9–28·3] in the Mediterranean diet group vs 37·7 [37·5–37·9] in the low-fat group, log-rank p=0·039). Multivariable-adjusted hazard ratios (HRs) of the different models ranged from 0·719 (95% CI 0·541–0·957) to 0·753 (0·568–0·998) in favour of the Mediterranean diet. These effects were more evident in men, with primary endpoints occurring in 67 (16·2%) of 414 men in the Mediterranean diet group versus 94 (22·8%) of 413 men in the low-fat diet group (multiadjusted HR 0·669 [95% CI 0·489–0·915], log-rank p=0·013), than in 175 women for whom no difference was found between groups. Interpretation: In secondary prevention, the Mediterranean diet was superior to the low-fat diet in preventing major cardiovascular events. Our results are relevant to clinical practice, supporting the use of the Mediterranean diet in secondary prevention. Funding: Fundacion Patrimonio Comunal Olivarero; Fundacion Centro para la Excelencia en Investigacion sobre Aceite de Oliva y Salud; local, regional, and national Spanish Governments; European Union.
AB - Background: Mediterranean and low-fat diets are effective in the primary prevention of cardiovascular disease. We did a long-term randomised trial to compare the effects of these two diets in secondary prevention of cardiovascular disease. Methods: The CORDIOPREV study was a single-centre, randomised clinical trial done at the Reina Sofia University Hospital in Córdoba, Spain. Patients with established coronary heart disease (aged 20–75 years) were randomly assigned in a 1:1 ratio by the Andalusian School of Public Health to receive a Mediterranean diet or a low-fat diet intervention, with a follow-up of 7 years. Clinical investigators (physicians, investigators, and clinical endpoint committee members) were masked to treatment assignment; participants were not. A team of dietitians did the dietary interventions. The primary outcome (assessed by intention to treat) was a composite of major cardiovascular events, including myocardial infarction, revascularisation, ischaemic stroke, peripheral artery disease, and cardiovascular death. This study is registered with ClinicalTrials.gov, NCT00924937. Findings: From Oct 1, 2009, to Feb 28, 2012, a total of 1002 patients were enrolled, 500 (49·9%) in the low-fat diet group and 502 (50·1%) in the Mediterranean diet group. The mean age was 59·5 years (SD 8·7) and 827 (82·5%) of 1002 patients were men. The primary endpoint occurred in 198 participants: 87 in the Mediterranean diet group and 111 in the low-fat group (crude rate per 1000 person-years: 28·1 [95% CI 27·9–28·3] in the Mediterranean diet group vs 37·7 [37·5–37·9] in the low-fat group, log-rank p=0·039). Multivariable-adjusted hazard ratios (HRs) of the different models ranged from 0·719 (95% CI 0·541–0·957) to 0·753 (0·568–0·998) in favour of the Mediterranean diet. These effects were more evident in men, with primary endpoints occurring in 67 (16·2%) of 414 men in the Mediterranean diet group versus 94 (22·8%) of 413 men in the low-fat diet group (multiadjusted HR 0·669 [95% CI 0·489–0·915], log-rank p=0·013), than in 175 women for whom no difference was found between groups. Interpretation: In secondary prevention, the Mediterranean diet was superior to the low-fat diet in preventing major cardiovascular events. Our results are relevant to clinical practice, supporting the use of the Mediterranean diet in secondary prevention. Funding: Fundacion Patrimonio Comunal Olivarero; Fundacion Centro para la Excelencia en Investigacion sobre Aceite de Oliva y Salud; local, regional, and national Spanish Governments; European Union.
UR - http://www.scopus.com/inward/record.url?scp=85130230148&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(22)00122-2
DO - 10.1016/S0140-6736(22)00122-2
M3 - Article
C2 - 35525255
AN - SCOPUS:85130230148
SN - 0140-6736
VL - 399
SP - 1876
EP - 1885
JO - The Lancet
JF - The Lancet
IS - 10338
ER -